FDAnews
www.fdanews.com/articles/132338-glaxo-halts-development-of-resveratrol

Glaxo Halts Development of Resveratrol

December 2, 2010
GlaxoSmithKline PLC stopped development of SRT501, a drug designed to mimic the benefits of red wine, saying the medication didn’t work well enough in cancer patients and could worsen kidney damage.
boston